Prognostic impact of atrial fibrillation in hypertrophic cardiomyopathy: a systematic review

被引:23
作者
Alphonse, Patricia [1 ]
Virk, Sohaib [1 ]
Collins, Jhonna [2 ]
Campbell, Timothy [1 ,3 ]
Thomas, Stuart P. [1 ,3 ]
Semsarian, Christopher [4 ]
Kumar, Saurabh [1 ,3 ]
机构
[1] Westmead Hosp, Dept Cardiol, Corner Hawkesbury & Darcy Rd, Sydney, NSW 2145, Australia
[2] Univ Sydney, Nepean Clin Sch, Sydney, NSW, Australia
[3] Univ Sydney, Westmead Appl Res Ctr, Sydney, NSW, Australia
[4] Univ Sydney, Royal Prince Alfred Hosp, Dept Cardiol, Agnes Ginges Ctr Mol Cardiol,Centenary Inst, Sydney, NSW, Australia
关键词
Hypertrophic cardiomyopathy; Atrial fibrillation; Morbidity; Mortality; Thromboembolism; Heart failure; Sudden death; CLINICAL-COURSE; RISK; OUTCOMES; PROFILE; THROMBOEMBOLISM; MORTALITY; SURVIVAL; STROKE; DEATH;
D O I
10.1007/s00392-020-01730-w
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Atrial fibrillation (AF) is an important arrhythmia in hypertrophic cardiomyopathy (HCM). Objectives To conduct a systematic review of published literature to: (a) assess the incidence of AF in HCM and (b) examine the impact of AF on risk of thromboembolism, heart failure, sudden death and mortality in HCM. Methods Search of all major databases (Pubmed, MEDLINE, Embase, Cochrane, Scopus, Web of Science) was performed to April 2020 using the search terms "atrial fibrillation" AND/OR "hypertrophic cardiomyopathy" in the title or abstract. 51 of the 1,565 citations met the inclusion criteria. Results Using random-effects modelling, the estimated pooled prevalence of AF amongst 21,887 HCM patients (36 studies) was 22.3% (95%, 19.9-24.8) and the pooled incidence of AF was 2.5 cases per person-years (95% CI 1.9-3.0). 15,444 patients from 28 studies were included in analysis of outcome data (mean age was 49.9 years; 32.7% female; mean LVEF 69%). Over a median follow up duration of 6.9 years (range 2.8-11.7 years), AF, compared to sinus rhythm (SR), was associated with significantly increased risk of thromboembolism [relative risk (RR) 7.0; 95% CI 4.6-10.7; I-2 = 57%], heart failure (RR 2.8; 95% CI 1.6-4.6; I-2 = 82%), sudden death (RR 1.7; 95% CI 1.3-2.3; I-2 = 0%), and all-cause mortality (RR 2.5; 95% CI 1.8-3.4; I-2 = 69%). Conclusions AF is highly prevalent in patients with HCM. The presence of AF is associated with major adverse clinical outcomes. These findings suggest that both, aggressive screening and treatment of AF, are likely to have major prognostic impact on outcomes in HCM.
引用
收藏
页码:544 / 554
页数:11
相关论文
共 47 条
[1]  
Albanesi Filho F M, 1994, Arq Bras Cardiol, V62, P337
[2]   Factors Predicting Long-Term Mortality in Patients with Hypertrophic Cardiomyopathy [J].
Bostan, Cem ;
Sinan, Umit Yasar ;
Canbolat, Polat ;
Abaci, Okay ;
Munipoglu, Sezer Karcier ;
Kucukoglu, Serdar .
ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES, 2014, 31 (09) :1056-1061
[3]   Prognostic significance of exercise induced arrhythmias and echocardiographic variables in hypertrophic cardiomyopathy [J].
Bunch, T. Jared ;
Chandrasekaran, Krishnaswamy ;
Ehrsam, Jo-Ellen ;
Hammill, Stephen C. ;
Urban, Lynn H. ;
Hodge, David O. ;
Ommen, Steve R. ;
Pellikka, Patricia A. .
AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (06) :835-838
[4]   The Italian registry for hypertrophic cardiomyopathy: A nationwide survey [J].
Cecchi, F ;
Olivotto, L ;
Betocchi, S ;
Rapezzi, C ;
Conte, MR ;
Sinagra, G ;
Zachara, E ;
Gavazzi, A ;
Rordorf, R ;
Carnemolla, G ;
Porcu, M ;
Nistri, S ;
Gruppillo, P ;
Giampaoli, S .
AMERICAN HEART JOURNAL, 2005, 150 (05) :947-954
[5]   HYPERTROPHIC CARDIOMYOPATHY IN TUSCANY - CLINICAL COURSE AND OUTCOME IN AN UNSELECTED REGIONAL POPULATION [J].
CECCHI, F ;
OLIVOTTO, I ;
MONTEREGGI, A ;
SANTORO, G ;
DOLARA, A ;
MARON, BJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1995, 26 (06) :1529-1536
[6]   REVISITING PROGNOSTIC IMPACT OF ATRIAL FIBRILLATION IN HYPERTROPHIC CARDIOMYOPATHY [J].
Corona Guerrero, Jose Carlos ;
Jimenez-Baena, Elena ;
Martinez-Martinez, Angel ;
Valle-Racero, Juan ;
Francisco, Lopez-Pardo ;
Lopez-Haldon, Jose ;
Urbano-Moral, Jose .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) :1515-1515
[7]   Left Atrial Size and Function in Hypertrophic Cardiomyopathy Patients and Risk of New-Onset Atrial Fibrillation [J].
Debonnaire, Philippe ;
Joyce, Emer ;
Hiemstra, Yasmine ;
Mertens, Bart J. ;
Atsma, Douwe E. ;
Schalij, Martin J. ;
Bax, Jeroen J. ;
Delgado, Victoria ;
Marsan, Nina Ajmone .
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2017, 10 (02)
[8]   2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC) [J].
Elliott, Perry M. ;
Anastasakis, Aris ;
Borger, Michael A. ;
Borggrefe, Martin ;
Cecchi, Franco ;
Charron, Philippe ;
Hagege, Albert Alain ;
Lafont, Antoine ;
Limongelli, Giuseppe ;
Mahrholdt, Heiko ;
McKenna, William J. ;
Mogensen, Jens ;
Nihoyannopoulos, Petros ;
Nistri, Stefano ;
Pieper, Petronella G. ;
Pieske, Burkert ;
Rapezzi, Claudio ;
Rutten, Frans H. ;
Tillmanns, Christoph ;
Watkins, Hugh .
EUROPEAN HEART JOURNAL, 2014, 35 (39) :2733-+
[9]   EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication [J].
Goette, Andreas ;
Kalman, Jonathan M. ;
Aguinaga, Luis ;
Akar, Joseph ;
Angel Cabrera, Jose ;
Chen, Shih Ann ;
Chugh, Sumeet S. ;
Corradi, Domenico ;
D'Avila, Andre ;
Dobrev, Dobromir ;
Fenelon, Guilherme ;
Gonzalez, Mario ;
Hatem, Stephane N. ;
Helm, Robert ;
Hindricks, Gerhard ;
Ho, Siew Yen ;
Hoit, Brian ;
Jalife, Jose ;
Kim, Young-Hoon ;
Lip, Gregory Y. H. ;
Ma, Chang-Sheng ;
Marcus, Gregory M. ;
Murray, Katherine ;
Nogami, Akihiko ;
Sanders, Prashanthan ;
Uribe, William ;
Van Wagoner, David R. ;
Nattel, Stanley .
EUROPACE, 2016, 18 (10) :1455-1490
[10]   Oxidative stress and microcirculatory flow abnormalities in the ventricles during atrial fibrillation [J].
Goette, Andreas ;
Bukowska, Alicja ;
Lillig, Christopher H. ;
Lendeckel, Uwe .
FRONTIERS IN PHYSIOLOGY, 2012, 3